In What Clinical Setting Should Immunotherapies Be Developed?

In What Clinical Setting Should Immunotherapies Be Developed?

Da: GRACEcast
0 0 6 anni fa
Dr. Charles Rudin of Memorial Sloan Kettering discusses immune therapies that show promise in fighting lung cancer. February 2014.

Seguici su Facebook